Blog

AbbVie's revenue miss raises concerns over Humira sales

AbbVie reported total Humira sales of $3.54 billion for the quarter ended June 30, a 7.6 percent fall from a year earlier. Humira sales have grown on an average 19.2 percent over the past four quarters up to March, according to Thomson Reuters calculations, helped by approvals to treat more indications and expansion into newer markets. AbbVie blamed a change in shipment timing and a strong dollar for a 14.3

FDA approves Novartis's advanced skin cancer drug

(Reuters) – The U.S. Food and Drug Administration approved Novartis AG’s oral pill to treat the most common form of advanced skin cancer. The drug, Odomzo, will carry a boxed warning to alert the risks that it may cause death or severe birth defects in a developing fetus when administered to a pregnant woman. (http://1.usa.gov/1HOgvov) (Reporting by Anjali Rao Koppala in Bengaluru; Editing by Saumyadeb Chakrabarty)

Biogen halves sales growth forecast as Tecfidera demand stalls

Biogen’s stock fell as much as 18.8 percent to a seven-month low, wiping out about $17 billion of its value, after the company’s weak forecast and lackluster second-quarter results on Friday. Biogen needs “fixing”, and it does not have the luxury of time to build out its pipeline gradually like Celgene Corp does, Piper Jaffray’s Joshua Schimmer said. “I don’t think we’re in any panic situation but as we see

The Met’s “China: Through the Looking Glass” may outpace McQueen retrospective

Roberto Cavalli gown on display at The Met The Metropolitan Museum of Art’s Costume Institute has announced the expansion of its current exhibit “China: Through the Looking Glass” through Labor Day Weekend. China: Through the Looking Glass opened on May 7 and explores the influences Chinese culture has had on Western high-fashion through a juxtaposition of couture and avant-garde fashion pieces with Chinese art and cultural artifacts. While many brands